The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of SHR-1826, a c-MET–directed antibody-drug-conjugate (ADC), in advanced solid tumors.
 
Yang Zhang
No Relationships to Disclose
 
Longhua Sun
No Relationships to Disclose
 
Shengxiang Ren
No Relationships to Disclose
 
Feng Pan
No Relationships to Disclose
 
Haibo Zhu
No Relationships to Disclose
 
Qi Dang
No Relationships to Disclose
 
Panwen Tian
No Relationships to Disclose
 
Funan Liu
No Relationships to Disclose
 
Lin Wu
No Relationships to Disclose
 
Sanxing Guo
No Relationships to Disclose
 
Yudong Su
No Relationships to Disclose
 
Jun Zhang
No Relationships to Disclose
 
Yong Wang
No Relationships to Disclose
 
Kai Chen
No Relationships to Disclose
 
Rui Meng
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Yi Hu
No Relationships to Disclose
 
Yijun Jia
Employment - Jiangsu Hengrui Pharmaceuticals
 
Mingge Li
Employment - Jiangsu Hengrui Pharmaceuticals
 
Rui-Hua Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Hutchison MediPharma; Junshi Pharmaceuticals; Keymed Biosience; MSD; QiLu Pharmaceutical